Literature DB >> 25893310

Diagnosis and management of asthma in preschoolers: A Canadian Thoracic Society and Canadian Paediatric Society position paper.

Francine M Ducharme, Sharon D Dell, Dhenduka Radhakrishnan, Roland M Grad, Wade T A Watson, Connie L Yang, Mitchell Zelman.   

Abstract

Asthma often starts before six years of age. However, there remains uncertainty as to when and how a preschool-age child with symptoms suggestive of asthma can be diagnosed with this condition. This delays treatment and contributes to both short- and long-term morbidity. Members of the Canadian Thoracic Society Asthma Clinical Assembly partnered with the Canadian Paediatric Society to develop a joint working group with the mandate to develop a position paper on the diagnosis and management of asthma in preschoolers. In the absence of lung function tests, the diagnosis of asthma should be considered in children one to five years of age with frequent (≥ 8 days/month) asthma-like symptoms or recurrent (≥ 2) exacerbations (episodes with asthma-like signs). The diagnosis requires the objective document of signs or convincing parent-reported symptoms of airflow obstruction (improvement in these signs or symptoms with asthma therapy), and no clinical suspicion of an alternative diagnosis. The characteristic feature of airflow obstruction is wheezing, commonly accompanied by difficulty breathing and cough. Reversibility with asthma medications is defined as direct observation of improvement with short-acting ß2-agonists (SABA) (with or without oral corticosteroids) by a trained health care practitioner during an acute exacerbation (preferred method). However, in children with no wheezing (or other signs of airflow obstruction) on presentation, reversibility may be determined by convincing parental report of a symptomatic response to a three-month therapeutic trial of a medium dose of inhaled corticosteroids with as-needed SABA (alternative method), or as-needed SABA alone (weaker alternative method). The authors provide key messages regarding in whom to consider the diagnosis, terms to be abandoned, when to refer to an asthma specialist and the initial management strategy. Finally, dissemination plans and priority areas for research are identified.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25893310      PMCID: PMC4470545          DOI: 10.1155/2015/101572

Source DB:  PubMed          Journal:  Can Respir J        ISSN: 1198-2241            Impact factor:   2.409


  44 in total

1.  A clinical index to define risk of asthma in young children with recurrent wheezing.

Authors:  J A Castro-Rodríguez; C J Holberg; A L Wright; F D Martinez
Journal:  Am J Respir Crit Care Med       Date:  2000-10       Impact factor: 21.405

Review 2.  Use of health diaries in pediatric research.

Authors:  Arlene Butz
Journal:  J Pediatr Health Care       Date:  2004 Sep-Oct       Impact factor: 1.812

3.  Intermittent inhaled corticosteroids in infants with episodic wheezing.

Authors:  Hans Bisgaard; Mette Northman Hermansen; Lotte Loland; Liselotte Brydensholt Halkjaer; Frederik Buchvald
Journal:  N Engl J Med       Date:  2006-05-11       Impact factor: 91.245

Review 4.  Long-term outcomes of early-onset wheeze and asthma.

Authors:  Roni Grad; Wayne J Morgan
Journal:  J Allergy Clin Immunol       Date:  2012-06-26       Impact factor: 10.793

Review 5.  Early emergency department treatment of acute asthma with systemic corticosteroids.

Authors:  B H Rowe; C Spooner; F M Ducharme; J A Bretzlaff; G W Bota
Journal:  Cochrane Database Syst Rev       Date:  2000

Review 6.  Diagnosis, management, and prognosis of preschool wheeze.

Authors:  Francine M Ducharme; Sze M Tse; Bhupendrasinh Chauhan
Journal:  Lancet       Date:  2014-05-03       Impact factor: 79.321

7.  Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma.

Authors:  Stanley J Szefler; James W Baker; Tom Uryniak; Mitchell Goldman; Philip E Silkoff
Journal:  J Allergy Clin Immunol       Date:  2007-11       Impact factor: 10.793

8.  Use of dexamethasone and prednisone in acute asthma exacerbations in pediatric patients.

Authors:  Allan E Shefrin; Ran D Goldman
Journal:  Can Fam Physician       Date:  2009-07       Impact factor: 3.275

Review 9.  Cough and asthma.

Authors:  Peter P van Asperen
Journal:  Paediatr Respir Rev       Date:  2006-01-24       Impact factor: 2.726

10.  Managing the paediatric patient with an acute asthma exacerbation.

Authors:  Oliva Ortiz-Alvarez; Angelo Mikrogianakis
Journal:  Paediatr Child Health       Date:  2012-05       Impact factor: 2.253

View more
  22 in total

1.  Treating asthma flareups at home - an opinion.

Authors:  Daniel Hughes
Journal:  Paediatr Child Health       Date:  2015 Nov-Dec       Impact factor: 2.253

Review 2.  Maybe there is no such thing as bronchiolitis.

Authors:  Brian A Kuzik
Journal:  CMAJ       Date:  2016-02-01       Impact factor: 8.262

3.  Comment on the CTS 2015 guidelines for asthma in preschoolers.

Authors:  Israel Amirav; Michael T Newhouse
Journal:  Paediatr Child Health       Date:  2017-04-17       Impact factor: 2.253

Review 4.  Management of Recurrent Preschool, Doctor-Diagnosed Wheeze.

Authors:  Ka-Ka Siu; Shuk-Yu Leung; Sum-Yi Kong; Daniel Kwok-Keung Ng
Journal:  Indian J Pediatr       Date:  2018-01-08       Impact factor: 1.967

5.  The routine use of oral steroids in paediatric asthma is not routine.

Authors:  Brian A Kuzik
Journal:  Paediatr Child Health       Date:  2018-04-07       Impact factor: 2.253

6.  Neuropsychiatric adverse drug reactions in children initiated on montelukast in real-life practice.

Authors:  Brigitte Benard; Valérie Bastien; Benjamin Vinet; Roger Yang; Maja Krajinovic; Francine M Ducharme
Journal:  Eur Respir J       Date:  2017-08-17       Impact factor: 16.671

Review 7.  Question 3: Can we diagnose asthma in children under the age of 5 years?

Authors:  C L Yang; J M Gaffin; D Radhakrishnan
Journal:  Paediatr Respir Rev       Date:  2018-10-24       Impact factor: 2.726

8.  A diagnostic codes-based algorithm improves accuracy for identification of childhood asthma in archival data sets.

Authors:  Hee Yun Seol; Chung-Il Wi; Euijung Ryu; Katherine S King; Rohit D Divekar; Young J Juhn
Journal:  J Asthma       Date:  2020-05-20

9.  Atopic asthma as a potentially significant but unrecognized risk factor for Kawasaki disease in children.

Authors:  Bong Seok Choi; Editt Nikoyan Taslakian; Chung-Il Wi; Youn Ho Shin; Hee Yun Seol; Euijung Ryu; Thomas G Boyce; Jonathan N Johnson; Katherine S King; Jung Hyun Kwon; Young J Juhn
Journal:  J Asthma       Date:  2021-09-01

10.  Artificial intelligence-assisted clinical decision support for childhood asthma management: A randomized clinical trial.

Authors:  Hee Yun Seol; Pragya Shrestha; Joy Fladager Muth; Chung-Il Wi; Sunghwan Sohn; Euijung Ryu; Miguel Park; Kathy Ihrke; Sungrim Moon; Katherine King; Philip Wheeler; Bijan Borah; James Moriarty; Jordan Rosedahl; Hongfang Liu; Deborah B McWilliams; Young J Juhn
Journal:  PLoS One       Date:  2021-08-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.